P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo
1996

P-glycoprotein and Drug Resistance in Lung Cancer

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Y Abe, M Nakamura, Y Ohnishi, M Yoshimura, E Otal, Y Ozeki, Y Oshika, T Tokunaga, H Yamazaki, Y Ueyama, T Ogata, N Tamaoki

Primary Institution: Tokai University School of Medicine

Hypothesis

Acquired multidrug resistance is induced by the increased expression of P-glycoprotein in lung cancer in vivo.

Conclusion

The study suggests that overexpression of P-glycoprotein is related to acquired multidrug resistance in lung cancer.

Supporting Evidence

  • VCR-resistant variants showed increased levels of MDR1 expression.
  • LC-6 and Lu-24 were initially sensitive to both vincristine and doxorubicin.
  • Co-administration of CysA reversed acquired drug resistance in LC-6R.

Takeaway

This study found that lung cancer cells can become resistant to drugs because they produce more of a protein called P-glycoprotein, which helps them survive treatment.

Methodology

The study involved creating drug-resistant variants of lung cancer xenografts and testing their sensitivity to chemotherapy drugs while measuring P-glycoprotein expression.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication